Charlotte's Web Holdings, Inc. has appointed Dr. Marcel Bonn-Miller as its chief scientific officer.

Bonn-Miller brings more than two decades of cannabis and cannabinoid research experience to Charlotte's Web. Prior to joining Charlotte's Web, he served four years at Canopy Growth Corporation, most recently as vice president of human and animal research.

In addition to his work at Canopy Growth, Bonn-Miller has held positions as director of cannabinoid research at Zynerba Pharmaceuticals, adjunct assistant professor at the University of Pennsylvania Perelman School of Medicine, and health science specialist at the Department of Veterans Affairs in Palo Alto, California.

In his new role, Bonn-Miller will lead the company's R&D portfolio, including new product development, pre-clinical and clinical research, scientific regulatory support and alternative botanical wellness. He will build upon the company's existing safety and toxicology data and interface with the FDA's science teams to support regulatory pathways for hemp CBD extracts.

"The known and potential therapeutic effects of the hemp plant and its compounds are extraordinary," Bonn-Miller said. "A natural therapeutic from such a complex plant requires exceptional consistency in genetics and cultivation. This is where Charlotte's Web has uniquely excelled and provides an unprecedented opportunity to apply the significant knowledge accumulated over recent years in cannabinoid science."

Bonn-Miller has published over 150 research papers on cannabinoid science and co-authored three patents related to the use of CBD in the treatment of psychological illnesses. Additionally, he has formally reviewed a significant number of medical articles and books on cannabinoids, addiction and behavioral psychology and serves on the editorial boards of a number of scientific journals.

"We are honored to have Dr. Bonn-Miller join Charlotte's Web to lead our clinical science initiatives," said CEO Jacques Tortoroli. "His unparalleled clinical research record in cannabinoids is highly applicable for supporting our regulatory and scientific ambitions."

Bonn-Miller has received numerous research grants and awards of recognition for his research, including Researcher of the Year by Americans for Safe Access. He holds a Doctor of Philosophy (Ph.D.) in clinical psychology from the University of Vermont and was a postdoctoral fellow in the Center for Health Care Evaluation at the Veterans Affairs Palo Alto Health Care System & Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine. He is a member of the International Cannabinoid Research Society (ICRS) , American Psychological Association (APA), and College of Problems on Drug Dependence (CPDD).